News Sentiment

CRL sentiment intelligence

Charles River Laboratories news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 60 Balanced news tone 49 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 233.41 Week of 10 Jul 2026
Weighted tone 60/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

+1.2% over one week, +24.5% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Does Arovella CAR-iNKT NGS Partnership Deepen Charles River’s Cell Therapy Moat or Stretch CRL Too Thin?

Market Reaction

Balanced read

69/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction 1.2% Price digesting
Trend fit Trend inactive 24.5% over four weeks
Fair value 23.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 21
Neutral 25
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Ad Hoc News 8
Market source 7
simplywall.st 5
Stock Titan 4
TradingView 4
MarketWatch 3
MT Newswires 2
Moomoo 2

Event Lens

What the news is about

Classified themes
Market update 24
Analyst action 10
Earnings 6
Deals and strategy 5
Macro sensitivity 3
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49